ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Takeda exercises option to acquire Maverick Therapeutics for $525m
March 11, 2021Takeda Pharmaceutical Company has exercised its option to acquire Maverick Therapeutics for a pre-negotiated upfront payment and potential development and regulatory milestones totalling up to $525m. -
Genalyte Launches High-Speed COVID-19 Antibody Test
April 29, 2020First instrument-based, rapid test uses multi-antigen approach; U.S. FDA EUA submitted. -
Maverick Medical AI raises $700K
November 07, 2018The funding will be utilized for the company's development of its medical artificial intelligence-based solutions for identifying chronic disease in elderly populations.
Pharma Sources Insight January 2025
